| Medication Cleared for Atypical Hemolytic Uremic Syndrome - Renal and Urology News |
|
|
Renal and Urology News The drug, marketed by Alexion Pharmaceuticals, Inc., of Cheshire, Conn., under the name Soliris, is the first and only FDA approved treatment for aHUS, an extremely rare genetic disease that can lead to renal failure, stroke, and myocardial infarction. ... Alexion Pharmaceuticals' CEO Discusses FDA Approval of Soliris as a Treatment ... Seeking Alpha Soliris (eculizumab) Approved By FDA For Hemolytic Uremic Syndrome, A Rare |